Tert-butyl3-(4-fluorophenyl)-3-(hydroxymethyl)azetidine-1-carboxylate, 98%, 500mg

4-BROMO-5-METHYL-1H-PYRROLO[2,3-C]PYRIDINE, 1g

Isopropyl Formate>97.0%(GC)25mL

4-methyl-4'-pyrrolidinomethyl benzophenone, 97.0%, 1g

5-Amino-2-bromo-4-chlorobenzotrifluoride, 100g

rel-2-((1r,4r)-4-Aminocyclohexyl)acetonitrile hydrochloride, 97%, 250mg

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

Ethyl 2-chloro-5-fluoro-3-methylbenzoate, 97%, 500mg

4-(Hydroxymethyl)-1-naphthonitrile, 95.0%, 250mg

Methyl 5-cyclopropyl-1H-pyrazole-4-carboxylate, 95.0%, 25g

2-Formyl-5-methoxy-benzoic acid, 500mg

tert-Butyl 3-(hydroxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, 95%, 2g

8-Methyl-imidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 1g